You are here:
Pharma & Chemicals — Functional Products & Energy
Last Updated:February 28, 2026

About This Investor

JP-B-685

With roots in Japan, they are currently screening targets across Thailand, Singapore, Indonesia, Malaysia, Vietnam, Philippines, Australia (priority given to Thailand and Indonesia). EBIT of over 100 million yen (around 500 million yen is better) Minority investment, majority ownership, and 100% ownership are possible. Key target profile: Pharmaceuticals, fine chemicals, functional chemicals, health foods Trading…

Pharmaceuticals & Chemicals
Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam
Diversification
EBIT ≥ USD 0.65M (USD 3.3M+ ideal) | Minority/Majority/100% possible

Request Full Investor Profile

Similar Investors

JP-B-321

The stated objective is Expand existing businesses overseas. With roots

Philippines, Singapore, Thailand, Vietnam
Overseas Expansion
$3.27M - $32.7M
Majority preferred | Minority possible
JP-B-578

They are looking for opportunities aligned with the following target

Overseas Expansion
$13.1M - $65.4M
Majority (rule) | Revenue ≥ USD 13.1M | Stable op margin ≥5% | Below ok if synergy
JP-B-66

Geographic and deal conditions are important for this mandate: Worldwide.

Measurement / Analytical Instruments
Overseas Expansion
$19.6M - $327.1M
100% only